Markets.com Logo

BEAM

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    16.1794$
  • Previous Close
    15.9183$
  • 52 Week Change
    21.73$
  • Day Range
    0.26$
  • 52 Week High/Low
    13.525$ - 35.25$
  • Dividend Per Share
    --
  • Market cap
    1 625 M$
  • EPS
    -1
  • Beta
    2.225
  • Volume
    --

About

The stock financial product symbol BEAM.US refers to Beam Therapeutics Inc., a biotechnology company focused on precision genetic medicines through base editing. The ".US" suffix generally indicates that the stock is listed on a United States stock exchange, specifically the Nasdaq. Beam Therapeutics aims to develop therapies for serious diseases by using a technology that enables precise and permanent changes to DNA bases, offering a potential alternative to traditional gene editing or gene therapy approaches.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Stock Price of BEAM.US: Clinical Trial Results: Positive or negative data from clinical trials significantly impacts investor confidence and valuation.

Regulatory Approvals: FDA decisions on BEAM's therapies influence market access and revenue potential.

Market Sentiment: Overall investor optimism or pessimism towards biotechnology stocks affects BEAM's share price.

Competition: The presence of rival gene editing technologies impacts BEAM's market share and competitive advantage.

Financial Performance: BEAM's cash runway, research & development spending, and any potential revenue streams affect valuation.

Partnerships & Collaborations: Strategic alliances with larger pharmaceutical companies influence development progress and funding.

Broader Economic Conditions: Macroeconomic factors like interest rates and inflation impact overall investment decisions and risk appetite.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--